Re-immunisation schedule in leukaemic children after intensive chemotherapy: A possible strategy

European Journal of Haematology

Volumn 74, Issue 1, 2005, Pages 20-23

  Fioredda, Francesca ^a   Plebani, Alessandro ^b   Hanau, Guia ^a   Haupt, Riccardo ^a   Giacchino, Mareva ^c   Barisone, Elena ^c   Balbo, Luciano ^c   Castagnola, Elio ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

Acute lymphoblastic leukaemia; Immunocompromised children; Re immunisation schedule; Residual immunity

Indexed keywords

ANTILEUKEMIC AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; POLIOMYELITIS VACCINE; TETANUS ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBODY TITER; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; HEALTH CARE COST; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; ITALY; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; RETROSPECTIVE STUDIES; TETANUS;

EID: 12444292837     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00340.x     Document Type: Article

References (10)

1. ALANKO S, PELLINIEMI TT, SALMI TT. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992;69:1481-1486.
2. DE VAAN GA, VAN MUNSTER PJ, BAKKEREN JA. Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood. Eur J Pediatr 1982;139:113-117.
3. NILSSON A, DE MILITO A, ENGSTROM P, NORDIN M, NARITA M, GRILLNER L, CHIODI F, BJORK O. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 2002;109:e91.
4. FELDMAN S, ANDREW M, NORRIS M, MCINTYRE B, IYER R. Decline in rates of seropositivity for measles, mumps and rubella antibodies among previously immunized children treated for acute leukemia. Clin In Dis 1998;27:388-390.
5. ARICO' M, VALSECCHI MG, CONTER V, et al. Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II. Blood 2002;100:420-426.
6. BUCKLEY RH, MARKERT ML. B-cell development and function. In: RUDOLPH AM, HOFFMAN JIE, RUDOLPH CD, eds. Pediatrics. Stamford, CT: Appleton and Lane, 1996:433-435.
7. Royal College of Pediatrics and Child Health. Immunization of the immunocompromised child: best practice statement. February 2002. Available online at http://www.rcpch.ac.uk
8. BELLONI C, PISTORIO A, TINELLI C, KOMAKEC J, CHIRICO G, ROVELLI D, GULMINETTI R, COMOLLI G, ORSOLINI P, RONDINI G. Early immunization with hepatitis B vaccine: a five year study. Vaccine 2000;19:1307-1311.
9. WEST DJ, CALANDRA GB. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 1996;11:1019-1027.
10. STROFFOLINI T, GIAMMANCO A, GIAMMANCO G, TAORMINA S, MAGGIO M, GENOVESE M, DE MATTIA D, CHIARAMONTE M, SCARPA B, GENOVESE R. Immunity to tetanus in the 3-20 year age group in Italy. Public Health 1997;111: 19-21.